HYPERLIPOPROTEINEMIA(A) IN FAMILIAL HYPERCHOLESTEROLEMIA

被引：0
|
作者：
Chubykina, U. V. [1 ]
Bliznyuk, S. A. [1 ]
Afanasieva, M. I. [2 ]
Tmoyan, N. A. [1 ]
机构：
[1] Natl Med Res Ctr Cardiol, Lab Lipid Disorders, Moscow, Russia
[2] FSBO Natl Med Res Ctr Cardiol, Lab Problems Atherosclerosis, Moscow, Russia
来源：
ATHEROSCLEROSIS | 2021年 / 331卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P185
引用
收藏
页码：E117 / E117
页数：1
相关论文
共 50 条
  • [1] Migratory polyarthritis in familial hypercholesterolemia (type IIa hyperlipoproteinemia)
    Partha Pratim Chakraborty
    Sagnik Mukhopadhyay
    Arun Achar
    Mallika Pal
    Prabodh Chandra Mondal
    The Indian Journal of Pediatrics, 2010, 77 : 329 - 331
  • [2] MIGRATORY POLYARTHRITIS IN FAMILIAL HYPERCHOLESTEROLEMIA (TYPE 2 HYPERLIPOPROTEINEMIA)
    KHACHADURIAN, AK
    ARTHRITIS AND RHEUMATISM, 1968, 11 (03): : 385 - +
  • [3] Migratory Polyarthritis in Familial Hypercholesterolemia (Type IIa Hyperlipoproteinemia)
    Chakraborty, Partha Pratim
    Mukhopadhyay, Sagnik
    Achar, Arun
    Pal, Mallika
    Mondal, Prabodh Chandra
    INDIAN JOURNAL OF PEDIATRICS, 2010, 77 (03): : 329 - 331
  • [4] FAMILIAL HYPERCHOLESTEROLEMIA AND HYPERLIPOPROTEINEMIA(A) IN ACUTE CORONARY SYNDROME PATIENTS
    Bliznyuk, Svetlana
    Komarova, Anna
    Khrustaleva, Alyona
    Emelyanova, Elvira
    Ezhov, Marat
    ATHEROSCLEROSIS, 2024, 399
  • [5] CHANGES IN PLASMA LIPOPROTEIN SUBFRACTIONS IN PATIENTS WITH POLYGENIC HYPERCHOLESTEROLEMIA, FAMILIAL COMBINED HYPERLIPOPROTEINEMIA, AND FAMILIAL HYPERCHOLESTEROLEMIA AFTER ATORVASTATIN
    Muinjonov, B.
    Giyazitdinova, E.
    ATHEROSCLEROSIS, 2016, 252 : E45 - E45
  • [6] GEMFIBROZIL IN THE TREATMENT OF RESISTANT FAMILIAL HYPERCHOLESTEROLEMIA AND TYPE-III HYPERLIPOPROTEINEMIA
    HOULSTON, R
    QUINEY, J
    WATTS, GF
    LEWIS, B
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1988, 81 (05) : 274 - 276
  • [7] JOINT EFFECT OF FAMILIAL HYPERCHOLESTEROLEMIA AND HYPERLIPOPROTEINEMIA(A) ON THE RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Barkas, F.
    Anastasiou, G.
    Adamidis, P.
    Koutsogianni, A.
    Styla, C.
    Rizos, C.
    Kyrili, K.
    Liamis, G.
    Liberopoulos, E.
    ATHEROSCLEROSIS, 2022, 355 : E137 - E137
  • [8] HYPERLIPOPROTEINEMIA(A) AS A RISK FACTOR OF CORONARY HEART DISEASE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Bliznyuk, S.
    Ezhov, M.
    Afanasieva, O.
    Afanasieva, M.
    Pokrovsky, S.
    ATHEROSCLEROSIS, 2018, 275 : E163 - E163
  • [9] Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin
    Homma, Koichiro
    Homma, Yasuhiko
    Yoshida, Tadashi
    Ozawa, Hideki
    Shiina, Yutaka
    Wakino, Shu
    Hayashi, Koichi
    Itoh, Hiroshi
    Hori, Shingo
    JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (02) : 210 - 216
  • [10] COEXISTING TYPE-III HYPERLIPOPROTEINEMIA AND FAMILIAL HYPERCHOLESTEROLEMIA - A CASE-REPORT
    SAKUMA, N
    IWATA, S
    IKEUCHI, R
    ICHIKAWA, T
    HIBINO, T
    KAMIYA, Y
    OHTE, N
    KAWAGUCHI, M
    KUNIMATSU, M
    KAWAHARA, H
    FUJINAMI, T
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (04): : 460 - 465
12345